Magnera (NYSE:MAGN – Get Free Report) and UPM-Kymmene (OTCMKTS:UPMKY – Get Free Report) are both construction companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.
Risk & Volatility
Magnera has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, UPM-Kymmene has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500.
Earnings and Valuation
This table compares Magnera and UPM-Kymmene”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Magnera | $1.31 billion | 0.56 | -$60.00 million | ($18.34) | -1.12 |
| UPM-Kymmene | $12.38 billion | 1.14 | $1.77 billion | $2.65 | 9.98 |
Insider and Institutional Ownership
76.9% of Magnera shares are owned by institutional investors. Comparatively, 0.6% of UPM-Kymmene shares are owned by institutional investors. 2.3% of Magnera shares are owned by company insiders. Comparatively, 1.0% of UPM-Kymmene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Magnera and UPM-Kymmene’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Magnera | -6.97% | -10.62% | -3.97% |
| UPM-Kymmene | 13.76% | 12.57% | 8.65% |
Analyst Recommendations
This is a summary of recent recommendations for Magnera and UPM-Kymmene, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Magnera | 0 | 0 | 1 | 0 | 3.00 |
| UPM-Kymmene | 0 | 0 | 0 | 0 | 0.00 |
Magnera currently has a consensus price target of $24.00, indicating a potential upside of 16.45%. Given Magnera’s stronger consensus rating and higher probable upside, equities analysts clearly believe Magnera is more favorable than UPM-Kymmene.
Summary
UPM-Kymmene beats Magnera on 8 of the 14 factors compared between the two stocks.
About Magnera
Magnera’s purpose is to better the world with new possibilities made real. By continuously co-creating and innovating with our partners, we develop original material solutions that make a brighter future possible. With a breadth of technologies and a passion for what we create, Magnera’s solutions propel our customers’ goals forward and solve end-users’ problems, every day.
About UPM-Kymmene
UPM-Kymmene Oyj operates in the forest-based bio industry. It operates through UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and Other operations segments. The company provides eucalyptus, birch, and softwood pulp grades for tissue, specialty and graphic papers, boards, and packaging; sawn timber for construction, packaging, distribution, joinery, and furniture industries; and wood-based renewable diesel and renewable naphtha for fuel distributors, transportation, and oil and petrochemicals industries. It is also involved in the generation of electricity through hydro, nuclear, and condensing power plants. In addition, the company offers self-adhesive papers and film label stocks for product and information labelling to label printers and brand owners in food, beverage, personal care, pharmaceutical, and retail segments; label papers and release liners, fine papers, and flexible packaging, as well as label and packaging papers production lines for retailers, printers, publishers, distributors, and paper converters; and graphic papers for advertising, magazines, newspapers, and home and office to publishers, cataloguers, retailers, printers, and merchants. Further, it provides plywood and veneer products for construction, vehicle flooring, liquefied natural gas shipbuilding, and other manufacturing industries; wood and wood-based biomass, and forestry services for woodland and forest owners; outdoor products for construction, and granulates for injection molding and extrusion; wood-based lignin products for industrial use and cell culture hydrogel products for biomedical applications; and biomedical products. The company primarily operates in Europe, North America, and Asia. UPM-Kymmene Oyj was founded in 1995 and is headquartered in Helsinki, Finland.
Receive News & Ratings for Magnera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magnera and related companies with MarketBeat.com's FREE daily email newsletter.
